Journal of Affective Disorders
Volume 102, Issue 1 , Pages 1-9 , September 2007

The sales of antidepressants and suicide rates in Norway and its counties 1980–2004

  • Jørgen G. Bramness

      Affiliations

    • Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    • ,
  • Fredrik A. Walby

      Affiliations

    • The Suicide Research and Prevention Unit, Faculty of Medicine, University of Oslo, Oslo, Norway
    • Diakonhjemmet Hospital, Oslo, Norway
    • Corresponding Author InformationCorresponding author. The Suicide Research and Prevention Unit, University of Oslo, Sognsvannsveien 21, Bygning 12, 2. etg., NO-0320 Oslo, Norway. Tel.: +47 22 92 34 73; fax: +47 22 92 39 58.
    • ,
  • Aage Tverdal

      Affiliations

    • Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway

Received 8 November 2006 ,Revised 30 November 2006 ,Accepted 1 December 2006.

References 

  1. Barbui C, Campomori A, D'avanzo B, Negri E, Garattini S. Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences abd impact on suicide rates. Soc. Psychiatry Psychiatr. Epidemiol. 1999;34:152–156
  2. Berglund M, Thelander S, Andreásson S, Franck J, Fridell M, Håkanson I, et al. Behandling av alcohol — och narkotikaproblem. In: En evidensbaserad kunskapssammenställning. Stockholm: Statens beredning för medicinsk utvärdering; 2001;
  3. Carlsten A, Waern M, Ekedahl A, Ranstam J. Antidepressant medication and suicide in Sweden. Pharmacoepidemiol. Drug Saf. 2001;10:525–530
  4. Cavanagh J, Carson A, Sharpe M, Lawrie S. Psychological autopsy studies of suicide: a systematic review. Psychol. Med. 2003;3:395–405
  5. Cochran D, Orcutt D. Application of least squares regression to relationships containing auto-correlated error terms. JASA. 1949;44:32–61
  6. De Leo D. Why are we not getting any closer to preventing suicide?. Br. J. Psychiatry. 2002;181:372–374
  7. Gibbons R, Hur K, Bhaumik D, Mann J. The relationhsip between antidepressant medication use and rate of suicide. Arch. Gen. Psychiatry. 2005;62:165–172
  8. Gibbons R, Hur K, Bhaumik D, Mann J. The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am. J. Psychiatry. 2006;163:1898–10904
  9. Gmel G, Rehm J, Ghazinouri A. Alcohol and suicide in Switzerland — an aggregate-level analysis. Drug Alcohol Rev. 1998;17:27–37
  10. Grunebaum M, Ellis S, Li S, Oquendo M, Mann J. Antidepressants and suicide risk in the United States, 1985–1999. J. Clin. Psychiatry. 2004;65:1456–1462
  11. Guaiana G, Andretta M, Corbari L, Mirandola M, Sorio A, D'avanzo B, et al. Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000. J. Clin. Psychiatry. 2005;66:750–755
  12. Gunnell D, Ashby D. Antidepressants and suicides: what is the balance of benifit to harm. BMJ. 2004;329:34–38
  13. Gunnell D, Saperia J, Ashley D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ. 2005;330:385–389
  14. Hall W, Mant A, Mitchell P, Rendle V, Hickie I, Mcmanus P. Association between antidepressant prescribing and suicide in Australia, 1991–2000: trend analysis. BMJ. 2003;326:1008
  15. Harris E, Barraclough B. Suicide as an outcome for mental disorder. A meta-analysis. Br. J. Psychiatry. 1997;170:205–228
  16. Helgason T, Tomasson H, Zoega T. Antidepressants and public health in Iceland. Time series analysis of national data. Br. J. Psychiatry. 2004;184:157–162
  17. Henriksson S, Isacsson G. Increased antidepressant use and fewer suicides in Jämtland county, Sweden, after a primary care education program on the treatment of depression. Acta Psychiatr. Scand. 2006;114:159–167
  18. Isacsson G. Suicide prevention — a medical breakthrough?. Acta Psychiatr. Scand. 2000;102:113–117
  19. Kahn RS, Kling MA, Wetzler S, Asnins GM, Van Praag H. Effect of m-chlorophenylpiperazine on plasma arginine-vasopressin concentrations in healthy subjects. Psychopharmacology. 1992;108:225–228
  20. Kelly C, Ansari T, Rafferty T, Stevenson M. Antidepressant prescribing and suicide rate in Northern Ireland. Eur. Psychiatr. 2003;18:325–328
  21. Kessing L. Severity of depressive episodes according to ICD-10: prediction of risk of relapse and suicide. Br. J. Psychiatry. 2004;184:153–156
  22. Khan A, Khan S, Kolts R, Brown WA. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am. J. Psychiatry. 2003;160:790–792
  23. Lindsey J, Jones B. Choosing among generalized linear models applied to medical data. Stat. Med. 1998;17:59–68
  24. Ludwig J, Marcotte D. Anti-depressants, suicide and drug regulation. J. Policy Anal. Manag. 2005;24:249–272
  25. Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA. 2005;294:2064–2074
  26. Morgan O, Griffiths C, Majeed A. Association between mortality from suicide in England and antidepressant prescribing: an ecological study. BMC Public Health. 2004;4:63
  27. Olfson M, Shaffer D, Marcus S, Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Arch. Gen. Psychiatry. 2003;60:978–982
  28. Oravecz R, Czigler B, Leskoσek F. Correlation between suicide date and antidepressant use in Slovenia. Arch. Suicide Res. 2003;7:279–285
  29. Platt S, Hawton K. Suicidal behaviour and the labour market. In:  Hawton K,  Heeringen K editor. The International Handbook of Suicide and Attempted Suicide. Chichester: Wiley; 2006;
  30. Raferty A. Bayesian model selection in social research. Sociol. Method. 1995;25:111–163
  31. Reseland S, Bray I, Gunnell G. Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries. Br. J. Psychiatry. 2006;188:354–358
  32. Rihmer Z. Decreasing national suicide rates — fact or fiction. World J. Biol. Psychiatry. 2003;4:55–56
  33. Rihmer Z, Akiskal H. Do antidepressants t(h)reat(en) depressives? Toward a clinical judicious formulation of the antidepressant–suicidality FDA advisory in light of the declining national suicide statistics from many countries. J. Affect. Disord. 2006;94:3–13
  34. Rihmer Z, Belso N, Halmar S. Antidepressants and suicide prevention in Hungary. Acta Psychiatr. Scand. 2001;103:238–239
  35. Rihmer Z, Rutz W, Pihlgren H. Depression and suicide on Gotland. An intensive study of all suicides before and after a depression-training programme for general practitioners. J. Affect. Disord. 1995;35:147–152
  36. Rossow I. Regional analyses of alcohol and suicide in Norway: some empirical considerations. Suicide Life-Threat. Behav. 1995;25:401–409
  37. Rossow I. Substance abuse and suicidal behaviour. In:  Hawton K editors. Prevention and Treatment of Suicidal Behaviour: From Science to Practice. Oxford: Oxford University Press; 2005;
  38. Rutz W. Preventing suicide and premature death by education and treatment. J. Affect. Disord. 2001;62:123–129
  39. Sher L. Alcohol use and suicide rates. Med. Hypotheses. 2005;65:1010–1012
  40. Simon G, Savarino J, Operskalski B, Wang P. Suicide risk during antidepressant treatment. Am. J. Psychiatry. 2006;163:41–47
  41. Who Collaborating Centre for Drug Statistics Methodology . Guidelines for ATC Classification and DDD Assignment. Oslo: WHO; 2005;

PII: S0165-0327(06)00531-3

doi: 10.1016/j.jad.2006.12.002

Journal of Affective Disorders
Volume 102, Issue 1 , Pages 1-9 , September 2007

Article Tools

* Image Usage & Resolution